# PREvention of VENous ThromboEmbolism Following Radical Prostatectomy

Study · id `cardio:ct-nct03006562` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03006562](<https://clinicaltrials.gov/study/NCT03006562>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03006562

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 501 participants.

## Technical summary

Registry record NCT03006562. Randomized; single masking; primary purpose prevention. Start 2017-07-01 (actual); primary completion 2019-11-01 (actual). Results posted on 2020-02-28.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 501 participants (enrolled count; ClinicalTrials.gov record NCT03006562, source copy `cardio:ctgov-nct03006562-2020-08-05`, retrieved 2026-10-31)
- Started: 2017-07-01 (actual) (ClinicalTrials.gov record NCT03006562, source copy `cardio:ctgov-nct03006562-2020-08-05`, retrieved 2026-10-31)
- Primary completion: 2019-11-01 (actual) (ClinicalTrials.gov record NCT03006562, source copy `cardio:ctgov-nct03006562-2020-08-05`, retrieved 2026-10-31)
- Completion: 2019-11-01 (actual) (ClinicalTrials.gov record NCT03006562, source copy `cardio:ctgov-nct03006562-2020-08-05`, retrieved 2026-10-31)
- Results first posted: 2020-02-28 (ClinicalTrials.gov record NCT03006562, source copy `cardio:ctgov-nct03006562-2020-08-05`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT03006562, source copy `cardio:ctgov-nct03006562-2020-08-05`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03006562-2020-08-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
- Acronym: PREVENTER
- Condition: Prostate Cancer
- Condition: Venous Thromboembolism
- Condition: Lymphocele After Surgical Procedure
- Condition: Deep Venous Thrombosis
- Condition: Pulmonary Embolism
- Intervention (Drug): Subcutaneous Heparin
- Lead sponsor: Johns Hopkins University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Heparin (`cardio:heparin`)
- Registry intervention is a member of this class by a sourced record link: Heparins and low-molecular-weight heparins (`cardio:heparins-and-low-molecular-weight-heparins`)
- Registry intervention is a member of this class by a sourced record link: Anticoagulants (`cardio:anticoagulants`)
- Registry lists this organization as the lead sponsor: Johns Hopkins University (`cardio:org-johns-hopkins-university`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial (`cardio:pubmed-32444264`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0388d7e0f0585e674c3002f05a1f8b097c05a077159299a93c948f8bb9f16b72
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
